Institute Of Human Virology To Begin Human Clinical Trial Of HIV Vaccine Using Different Protection Technique
Baltimore Sun: HIV vaccine to be tested on people
“After years of research, a promising HIV/AIDS vaccine at the University of Maryland School of Medicine is moving into the critical human testing stage. The school’s Institute of Human Virology, headed by Dr. Robert Gallo, who helped discover the human immunodeficiency virus that causes AIDS and who developed the HIV blood test, announced the next big step in the research Thursday…” (McDaniels, 10/8).
ScienceInsider: AIDS pioneer finally brings AIDS vaccine to clinic
“…Gallo’s team has been developing a vaccine with an unusual method of protection for 15 years and is now launching the first clinical trial of it in collaboration with Profectus BioSciences, a biotech that spun off from IHV recently. Known as a phase I study, the trial expects to enroll 60 people and will simply assess safety and immune responses of the ‘full-length single chain’ vaccine. ‘It’s a terrible name,’ says Gallo, who is not one to mince words…” (Cohen, 10/8).